Balyasny Asset Management LLC Insmed Inc Put Options Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 13, 2024
SELL
$25.72 - $29.94 $218,620 - $254,490
-8,500 Reduced 1.57%
533,100 $14.5 Million
Q4 2023

Feb 14, 2024
BUY
$23.42 - $31.74 $224,832 - $304,704
9,600 Added 1.8%
541,600 $16.8 Million
Q3 2023

Nov 14, 2023
BUY
$19.86 - $26.93 $10.6 Million - $14.3 Million
532,000 New
532,000 $13.4 Million
Q2 2018

Aug 14, 2018
BUY
$20.0 - $29.72 $4.4 Million - $6.54 Million
220,000 New
220,000 $5.2 Million

Others Institutions Holding INSM

# of Institutions
465
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email